ProKidney Corp. (PROK)
2.18
-0.06
(-2.68%)
USD |
NASDAQ |
Jan 02, 12:20
ProKidney EPS Diluted (Quarterly): -0.122 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Lineage Cell Therapeutics, Inc. | -0.1301 |
| Erasca, Inc. | -0.1079 |
| CEL-SCI Corp. | -0.7611 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -35.84M |
| Revenue (Quarterly) | 0.217M |
| Total Expenses (Quarterly) | 16.69M |
| Enterprise Value | 1.376B |
| Gross Profit Margin (Quarterly) | -544.2% |
| Profit Margin (Quarterly) | -16.52K% |
| Earnings Yield | -24.98% |
| Normalized Earnings Yield | -23.64 |